Floatz logo

Human Allogeneic Cardiosphere-Derived Cells

Nervous System Disorder

Capricor Inc.Cell therapyPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

31 Active assets in the Nervous System Disorder cohort.

Asset / SponsorPhaseRating
Ginkgolide
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 4BB
Guanfacine
Maimonides Medical Center
Phase 4BB
Brexpiprazole
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3BB
D-Thioctic Acid
Ain Shams University
Phase 4BB
Live Combined Bifidobacterium
Beijing Friendship Hospital
Phase 4BB

View all 49 →

Same molecule, other indications

Human Allogeneic Cardiosphere-Derived Cells is also rated in:

Duchenne muscular dystrophyDormant
B
Indicative · Phase 2
63 / 100
View asset →
disease of genetic or genomic mechanismDormant
B
Indicative · Phase 2
57 / 100
View asset →
X-linked diseaseDormant
B
Indicative · Phase 2
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →